Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (M.P.C.).
University of British Columbia, St. Paul's Hospital, and the Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada (R.S.).
Ann Intern Med. 2019 Oct 15;171(8):547-554. doi: 10.7326/M19-1696. Epub 2019 Sep 17.
Administering antimicrobial agents before obtaining blood cultures could potentially decrease time to treatment and improve outcomes, but it is unclear how this strategy affects diagnostic sensitivity.
To determine the sensitivity of blood cultures obtained shortly after initiation of antimicrobial therapy in patients with severe manifestations of sepsis.
Patient-level, single-group, diagnostic study. (ClinicalTrials.gov: NCT01867905).
7 emergency departments in North America.
Adults with severe manifestations of sepsis, including systolic blood pressure less than 90 mm Hg or a serum lactate level of 4 mmol/L or more.
Blood cultures were obtained before and within 120 minutes after initiation of antimicrobial treatment.
Sensitivity of blood cultures obtained after initiation of antimicrobial therapy.
Of 3164 participants screened, 325 were included in the study (mean age, 65.6 years; 62.8% men) and had repeated blood cultures drawn after initiation of antimicrobial therapy (median time, 70 minutes [interquartile range, 50 to 110 minutes]). Preantimicrobial blood cultures were positive for 1 or more microbial pathogens in 102 of 325 (31.4%) patients. Postantimicrobial blood cultures were positive for 1 or more microbial pathogens in 63 of 325 (19.4%) patients. The absolute difference in the proportion of positive blood cultures between pre- and postantimicrobial testing was 12.0% (95% CI, 5.4% to 18.6%; P < 0.001). Sensitivity of postantimicrobial culture was 52.9% (CI, 42.8% to 62.9%). When the results of other microbiological cultures were included, microbial pathogens were found in 69 of 102 (67.6% [CI, 57.7% to 76.6%]) patients.
Only a proportion of screened patients were recruited.
Among patients with severe manifestations of sepsis, initiation of empirical antimicrobial therapy significantly reduces the sensitivity of blood cultures drawn shortly after treatment initiation.
Vancouver Coastal Health, St. Paul's Hospital Foundation Emergency Department Support Fund, the Fonds de recherche Santé-Québec, and the Maricopa Medical Foundation.
在采集血培养标本之前给予抗菌药物可能会缩短治疗时间并改善预后,但目前尚不清楚该策略如何影响诊断敏感性。
确定严重脓毒症表现患者在开始抗菌治疗后不久采集的血培养标本的敏感性。
患者水平、单组、诊断性研究。(ClinicalTrials.gov:NCT01867905)。
北美 7 家急诊部。
严重脓毒症表现的成年人,包括收缩压<90mmHg 或血清乳酸水平≥4mmol/L。
在开始抗菌治疗前和 120 分钟内采集血培养标本。
抗菌治疗开始后采集的血培养标本的敏感性。
在筛查的 3164 名患者中,325 名患者符合研究标准(平均年龄 65.6 岁;62.8%为男性),并在开始抗菌治疗后重复进行血培养(中位数时间 70 分钟[四分位距,50 至 110 分钟])。102/325(31.4%)名患者的预抗菌血培养标本中可检测到 1 种或多种微生物病原体。63/325(19.4%)名患者的抗菌后血培养标本中可检测到 1 种或多种微生物病原体。抗菌前和抗菌后检测的阳性血培养标本比例绝对差值为 12.0%(95%CI,5.4%至 18.6%;P<0.001)。抗菌后培养的敏感性为 52.9%(CI,42.8%至 62.9%)。当包括其他微生物培养的结果时,在 102 名患者中发现了微生物病原体(67.6%[CI,57.7%至 76.6%])。
仅招募了部分筛查患者。
在严重脓毒症表现的患者中,经验性抗菌治疗的开始显著降低了治疗开始后不久采集的血培养标本的敏感性。
温哥华海岸卫生局、圣保罗医院基金会急诊部支持基金、魁北克健康研究基金会和马里科帕医疗基金会。